| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 159.25M | 143.46M | 127.05M | 115.64M | 103.02M | 111.88M |
| Gross Profit | 45.00M | 70.46M | 69.58M | 63.56M | 61.31M | 67.64M |
| EBITDA | -24.47M | -20.24M | 35.80M | 33.72M | 37.21M | 39.72M |
| Net Income | -60.57M | -55.12M | 6.44M | 7.00M | 9.40M | 10.20M |
Balance Sheet | ||||||
| Total Assets | 241.70M | 254.69M | 230.87M | 218.68M | 208.34M | 228.48M |
| Cash, Cash Equivalents and Short-Term Investments | 5.09M | 13.09M | 15.76M | 13.82M | 15.33M | 23.04M |
| Total Debt | 114.73M | 115.01M | 58.09M | 53.58M | 56.62M | 77.66M |
| Total Liabilities | 183.30M | 191.16M | 107.47M | 98.12M | 89.45M | 111.91M |
| Stockholders Equity | 58.40M | 63.53M | 123.40M | 120.56M | 118.89M | 116.57M |
Cash Flow | ||||||
| Free Cash Flow | 8.79M | 14.10M | 24.13M | 23.04M | 24.52M | 23.00M |
| Operating Cash Flow | 16.62M | 25.35M | 35.94M | 33.89M | 35.46M | 40.06M |
| Investing Cash Flow | -58.85M | -62.21M | -21.69M | -21.16M | -10.23M | -19.15M |
| Financing Cash Flow | -19.90M | 34.20M | -12.31M | -14.24M | -32.93M | -13.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £735.58M | 8.86 | 60.89% | 5.54% | 7.83% | 2.36% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | £65.30M | 9.55 | -3.99% | ― | 0.46% | -257.14% | |
60 Neutral | £116.86M | -23.06 | 2.17% | ― | 11.02% | -59.83% | |
55 Neutral | £1.73M | -4.32 | ― | ― | ― | ― | |
46 Neutral | £13.81M | -3.01 | -9.36% | ― | -7.45% | 78.23% | |
43 Neutral | £19.25M | -0.96 | -99.34% | 23.79% | 25.44% | -1877.56% |